Magnesium in PDB 8tbm: Tricomplex of Rmc-7977, Kras G12V, and Cypa
Enzymatic activity of Tricomplex of Rmc-7977, Kras G12V, and Cypa
All present enzymatic activity of Tricomplex of Rmc-7977, Kras G12V, and Cypa:
3.6.5.2;
5.2.1.8;
Protein crystallography data
The structure of Tricomplex of Rmc-7977, Kras G12V, and Cypa, PDB code: 8tbm
was solved by
A.C.A.Tomlinson,
A.Chen,
J.E.Knox,
J.K.Yano,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
35.58 /
1.57
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
65.56,
84.09,
127.1,
90,
90,
90
|
R / Rfree (%)
|
17.8 /
21.1
|
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Tricomplex of Rmc-7977, Kras G12V, and Cypa
(pdb code 8tbm). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 2 binding sites of Magnesium where determined in the
Tricomplex of Rmc-7977, Kras G12V, and Cypa, PDB code: 8tbm:
Jump to Magnesium binding site number:
1;
2;
Magnesium binding site 1 out
of 2 in 8tbm
Go back to
Magnesium Binding Sites List in 8tbm
Magnesium binding site 1 out
of 2 in the Tricomplex of Rmc-7977, Kras G12V, and Cypa
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Tricomplex of Rmc-7977, Kras G12V, and Cypa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg202
b:17.2
occ:1.00
|
O1G
|
A:GNP201
|
2.0
|
17.8
|
1.0
|
O2B
|
A:GNP201
|
2.0
|
16.9
|
1.0
|
OG
|
A:SER17
|
2.1
|
15.5
|
1.0
|
O
|
A:HOH316
|
2.1
|
19.3
|
1.0
|
O
|
A:HOH332
|
2.1
|
16.6
|
1.0
|
OG1
|
A:THR35
|
2.1
|
16.3
|
1.0
|
CB
|
A:THR35
|
3.1
|
20.5
|
1.0
|
CB
|
A:SER17
|
3.2
|
19.0
|
1.0
|
PB
|
A:GNP201
|
3.2
|
16.9
|
1.0
|
PG
|
A:GNP201
|
3.2
|
18.2
|
1.0
|
N3B
|
A:GNP201
|
3.4
|
17.1
|
1.0
|
N
|
A:THR35
|
3.8
|
16.7
|
1.0
|
N
|
A:SER17
|
3.8
|
15.5
|
1.0
|
CA
|
A:THR35
|
4.1
|
17.3
|
1.0
|
OD2
|
A:ASP57
|
4.1
|
25.0
|
1.0
|
CA
|
A:SER17
|
4.1
|
15.9
|
1.0
|
O2G
|
A:GNP201
|
4.1
|
19.5
|
1.0
|
O2A
|
A:GNP201
|
4.2
|
19.1
|
1.0
|
O
|
A:HOH307
|
4.2
|
20.4
|
0.5
|
OD1
|
A:ASP57
|
4.2
|
24.2
|
1.0
|
CG2
|
A:THR35
|
4.2
|
20.0
|
1.0
|
O1B
|
A:GNP201
|
4.3
|
17.3
|
1.0
|
O3A
|
A:GNP201
|
4.3
|
17.1
|
1.0
|
O3G
|
A:GNP201
|
4.3
|
18.7
|
1.0
|
O
|
A:THR58
|
4.4
|
20.9
|
1.0
|
O
|
A:ASP33
|
4.5
|
18.8
|
1.0
|
CG
|
A:ASP57
|
4.5
|
25.3
|
1.0
|
O
|
A:HOH307
|
4.5
|
23.9
|
0.5
|
PA
|
A:GNP201
|
4.5
|
18.8
|
1.0
|
O1A
|
A:GNP201
|
4.6
|
18.8
|
1.0
|
C
|
A:PRO34
|
4.8
|
21.6
|
1.0
|
CB
|
A:LYS16
|
4.8
|
15.1
|
1.0
|
CE
|
A:LYS16
|
4.8
|
20.6
|
1.0
|
C
|
A:LYS16
|
4.9
|
16.6
|
1.0
|
CA
|
A:PRO34
|
4.9
|
22.0
|
1.0
|
|
Magnesium binding site 2 out
of 2 in 8tbm
Go back to
Magnesium Binding Sites List in 8tbm
Magnesium binding site 2 out
of 2 in the Tricomplex of Rmc-7977, Kras G12V, and Cypa
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Tricomplex of Rmc-7977, Kras G12V, and Cypa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg202
b:19.7
occ:1.00
|
O1G
|
B:GNP201
|
2.0
|
18.2
|
1.0
|
OG1
|
B:THR35
|
2.1
|
21.4
|
1.0
|
O
|
B:HOH322
|
2.1
|
21.7
|
1.0
|
OG
|
B:SER17
|
2.1
|
19.4
|
1.0
|
O2B
|
B:GNP201
|
2.1
|
21.0
|
1.0
|
O
|
B:HOH317
|
2.1
|
19.7
|
1.0
|
CB
|
B:THR35
|
3.1
|
20.5
|
1.0
|
CB
|
B:SER17
|
3.1
|
20.7
|
1.0
|
PG
|
B:GNP201
|
3.2
|
21.4
|
1.0
|
PB
|
B:GNP201
|
3.3
|
21.9
|
1.0
|
N3B
|
B:GNP201
|
3.5
|
23.7
|
1.0
|
N
|
B:THR35
|
3.8
|
21.2
|
1.0
|
N
|
B:SER17
|
3.8
|
19.6
|
1.0
|
OD2
|
B:ASP57
|
4.0
|
27.5
|
1.0
|
CA
|
B:SER17
|
4.0
|
17.2
|
1.0
|
CA
|
B:THR35
|
4.0
|
20.1
|
1.0
|
O
|
B:HOH366
|
4.1
|
44.8
|
1.0
|
O2A
|
B:GNP201
|
4.1
|
23.6
|
1.0
|
CG2
|
B:THR35
|
4.2
|
19.7
|
1.0
|
O2G
|
B:GNP201
|
4.2
|
21.1
|
1.0
|
OD1
|
B:ASP57
|
4.2
|
25.3
|
1.0
|
O1B
|
B:GNP201
|
4.3
|
20.6
|
1.0
|
O3G
|
B:GNP201
|
4.3
|
23.5
|
1.0
|
O3A
|
B:GNP201
|
4.4
|
21.2
|
1.0
|
O
|
B:THR58
|
4.4
|
21.3
|
1.0
|
O
|
B:ASP33
|
4.4
|
24.2
|
1.0
|
CG
|
B:ASP57
|
4.5
|
23.7
|
1.0
|
PA
|
B:GNP201
|
4.6
|
22.6
|
1.0
|
O1A
|
B:GNP201
|
4.6
|
21.9
|
1.0
|
C
|
B:PRO34
|
4.8
|
26.2
|
1.0
|
CB
|
B:LYS16
|
4.8
|
17.1
|
1.0
|
CE
|
B:LYS16
|
4.9
|
20.3
|
1.0
|
C
|
B:LYS16
|
4.9
|
17.8
|
1.0
|
CA
|
B:PRO34
|
4.9
|
25.9
|
1.0
|
|
Reference:
A.C.A.Tomlinson,
A.Chen,
J.E.Knox,
J.K.Yano.
Concurrent Inhibition of Oncogenic and Wild-Type Ras-Gtp For Cancer Therapy To Be Published.
Page generated: Fri Oct 4 20:35:52 2024
|